Projects per year
Personal profile
Personal profile
Dr. Suri is a gynecologic oncologist in the Department of Obstetrics and Gynecology at Houston Methodist Hospital. He grew up in Knoxville, Tennessee and received his medical degree from The University of Tennessee in Memphis in 2006. He completed a four year residency in the Department of Obstetrics, Gynecology, and Reproductive Sciences from the University of Texas Medical School in Houston Memorial Hermann Hospital. While a resident, he completed a one month Felix Rutledge Fellowship at The University of Texas MD Anderson Cancer Center and won the J. Taylor Wharton Award for Outstanding Resident in Gynecologic Oncology.
After completion of residency in 2010, Dr. Suri completed his Gynecologic Oncology Fellowship at the University of North Carolina Hospitals in Chapel Hill, North Carolina. During his training, Dr. Suri won several awards including Best Oral Presentation at the Winter Meeting of the Society of Gynecologic Oncology in 2012, the ASCO Merit Award at the 2012 American Society of Clinical Oncology Annual meeting, and The Golden Tarheel Award at The University of North Carolina. Dr. Suri has conducted basic science and clinical research covering topics such as ovarian cancer, granulosa cell tumors of the ovary, and vulvar cancer and presented his research at national conferences.
Research interests
Dr. Suri has extensive surgical and clinical training in the field of minimally invasive and robotic surgery. He also specializes in fertility sparing treatments and surgery for certain gynecologic cancers. He uses his clinical experience and multidisplinary approach to treat women with gynecologic cancers.
Professional Activity
- Texas Association of Obstetrics and Gynecology
- The Society of Gynecologic Oncologists
- American Society of Clinical Oncology
- Houston Methodist Cancer Center
Research Area Keywords
- Clinical Care
- Cancer
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
ARIA II: A Phase III Randomized Controlled Trial of Near-Infrared Angiography During Rectosigmoid Resection and Anastomosis in Women with Ovarian Cancer.
Zaid, T. (PI), Kamat, A. A. (Key Personnel), Ramirez, P. T. (Key Personnel), Snyder, M. J. (Key Personnel) & Suri, A. (Key Personnel)
1/13/25 → …
Project: Clinical Trial
-
A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy With No Retroperitoneal Node Dissection in Apparent Early-Stage Endometrial Cancer
Kamat, A. A. (Key Personnel), Ramirez, P. T. (Key Personnel), Suri, A. (Key Personnel) & Zaid, T. (Key Personnel)
7/24/24 → …
Project: Clinical Trial
-
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Ramirez, P. T. (PI), Kamat, A. A. (Key Personnel), Suri, A. (Key Personnel) & Zaid, T. (Key Personnel)
3/7/24 → …
Project: Clinical Trial
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A. (PI), Darcourt, J. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/15/21 → 3/14/46
Project: Non Profit
-
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864)) in addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Kamat, A. A. (PI), Darcourt, J. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/1/19 → 2/28/25
Project: Non Profit
-
Synchronous endometrial endometrioid adenocarcinoma and ovarian endometrioid adenocarcinoma
Rodríguez González, E., Deavers, M., Chang, S. & Suri, A., Feb 5 2024, In: International Journal of Gynecological Cancer. 34, 2, p. 332-338 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The association between progesterone receptor expression and survival in women with adult granulosa cell tumors
Puechl, A. M., Edwards, J., Suri, A., Nakayama, J., Bean, S., Gehrig, P., Saks, E., Duska, L., Broadwater, G., Ehrisman, J., Horowitz, N. & Secord, A. A., Apr 2019, In: Gynecologic oncology. 153, 1, p. 74-79 6 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer
Suri, A., Sheng, X., Schuler, K. M., Zhong, Y., Han, X., Jones, H. M., Gehrig, P. A., Zhou, C. & Bae-Jump, V. L., 2016, In: Oncotarget. 7, 26, p. 39582-39594 13 p.Research output: Contribution to journal › Article › peer-review
Open Access33 Scopus citations -
Discussion: 'Ovarian epithelial carcinoma with pelvic endometriosis,' by Wang et al
Van Le, L., Jackson, A., Schuler, K., Suri, A., Doll, K., Stine, J. & Kim, K., May 2013, In: American Journal of Obstetrics and Gynecology. 208, 5, p. e1-e2Research output: Contribution to journal › Comment/debate › peer-review
1 Scopus citations -
Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors
Suri, A., Carter, E. B., Horowitz, N., Denslow, S. & Gehrig, P. A., Nov 1 2013, In: Gynecologic oncology. 131, 2, p. 321-324 4 p.Research output: Contribution to journal › Article › peer-review
21 Scopus citations